Latest Licensing News

Page 70 of 164
Viridis Mining and Minerals has delivered a landmark Pre-Feasibility Study for its Colossus Rare Earth Project, confirming robust economics and securing key strategic funding and land expansions in Brazil.
Maxwell Dee
Maxwell Dee
29 Oct 2025
CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.
Claire Turing
Claire Turing
29 Oct 2025
Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.
Ada Torres
Ada Torres
29 Oct 2025
Great Southern Mining has sold a key mining license to Regis Resources for up to A$9 million and is progressing multiple drilling programs across its Australian projects, supported by government grants and a strategic alliance.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Ionic Rare Earths advances its global rare earths strategy with significant UK government funding, increased heavy rare earth oxide production, and a $15.6 million capital raise backed by a strategic US investor.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Ballard Mining accelerates exploration at its fully permitted Mt Ida Gold Project, revealing a substantial new exploration target alongside a robust existing resource base.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Tolu Minerals confirms multiple high-priority porphyry copper-gold targets at its Mt Penck project in Papua New Guinea, supported by an independent geophysical review and surrounded by active exploration including a major Rio Tinto application.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Lindian Resources secures official government confirmation that its Kangankunde Rare Earths Project is exempt from Malawi’s new raw mineral export ban, ensuring uninterrupted progress toward production.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.
Ada Torres
Ada Torres
29 Oct 2025
Ainsworth Game Technology’s board unanimously backs Novomatic’s $1.00 per share takeover offer, while a competing proportional bid at $1.30 per share emerges from a key shareholder.
Victor Sage
Victor Sage
29 Oct 2025
Sierra Nevada Gold (ASX, SNX) advances its Nevada gold projects with high-grade results and a new mining permit, while pursuing exploration licenses in Saudi Arabia and raising A$9.65 million in a strategic placement.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Condor Energy secures a 12-month extension for its offshore Peru exploration block and validates the Piedra Redonda gas field as a key regional energy asset with multiple commercialisation options.
Maxwell Dee
Maxwell Dee
29 Oct 2025